Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 9 |
GO:0110165 | cellular anatomical entity | 1 | 9 |
GO:0005737 | cytoplasm | 2 | 1 |
Related structures:
AlphaFold database: E9B1F4
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 5 | 7 | PF00675 | 0.469 |
CLV_NRD_NRD_1 | 51 | 53 | PF00675 | 0.411 |
CLV_PCSK_KEX2_1 | 51 | 53 | PF00082 | 0.392 |
CLV_PCSK_PC7_1 | 47 | 53 | PF00082 | 0.392 |
CLV_PCSK_SKI1_1 | 23 | 27 | PF00082 | 0.420 |
CLV_PCSK_SKI1_1 | 7 | 11 | PF00082 | 0.420 |
CLV_PCSK_SKI1_1 | 79 | 83 | PF00082 | 0.282 |
DEG_MDM2_SWIB_1 | 104 | 111 | PF02201 | 0.458 |
DOC_CYCLIN_RxL_1 | 75 | 83 | PF00134 | 0.606 |
DOC_MAPK_gen_1 | 54 | 62 | PF00069 | 0.496 |
DOC_MAPK_gen_1 | 75 | 84 | PF00069 | 0.588 |
DOC_USP7_MATH_1 | 85 | 89 | PF00917 | 0.407 |
DOC_USP7_UBL2_3 | 23 | 27 | PF12436 | 0.614 |
DOC_USP7_UBL2_3 | 75 | 79 | PF12436 | 0.588 |
DOC_WW_Pin1_4 | 109 | 114 | PF00397 | 0.376 |
LIG_14-3-3_CanoR_1 | 47 | 51 | PF00244 | 0.609 |
LIG_APCC_ABBA_1 | 60 | 65 | PF00400 | 0.590 |
LIG_EH1_1 | 75 | 83 | PF00400 | 0.588 |
LIG_EVH1_1 | 127 | 131 | PF00568 | 0.427 |
LIG_FHA_1 | 115 | 121 | PF00498 | 0.456 |
LIG_FHA_1 | 40 | 46 | PF00498 | 0.683 |
LIG_FHA_1 | 8 | 14 | PF00498 | 0.605 |
LIG_FHA_2 | 110 | 116 | PF00498 | 0.376 |
LIG_FHA_2 | 32 | 38 | PF00498 | 0.663 |
LIG_LIR_Gen_1 | 100 | 106 | PF02991 | 0.554 |
LIG_LIR_Nem_3 | 100 | 106 | PF02991 | 0.554 |
LIG_Pex14_2 | 104 | 108 | PF04695 | 0.458 |
LIG_SH2_STAT5 | 103 | 106 | PF00017 | 0.363 |
LIG_SH2_STAT5 | 98 | 101 | PF00017 | 0.313 |
LIG_SH3_3 | 125 | 131 | PF00018 | 0.431 |
LIG_SH3_3 | 86 | 92 | PF00018 | 0.309 |
LIG_WRC_WIRS_1 | 98 | 103 | PF05994 | 0.425 |
LIG_WW_1 | 130 | 133 | PF00397 | 0.444 |
MOD_CK2_1 | 31 | 37 | PF00069 | 0.636 |
MOD_CK2_1 | 58 | 64 | PF00069 | 0.605 |
MOD_GlcNHglycan | 117 | 120 | PF01048 | 0.679 |
MOD_N-GLC_1 | 21 | 26 | PF02516 | 0.395 |
MOD_N-GLC_1 | 85 | 90 | PF02516 | 0.333 |
MOD_NEK2_1 | 21 | 26 | PF00069 | 0.595 |
MOD_PKA_2 | 46 | 52 | PF00069 | 0.602 |
MOD_Plk_1 | 21 | 27 | PF00069 | 0.597 |
MOD_Plk_1 | 31 | 37 | PF00069 | 0.612 |
MOD_Plk_1 | 58 | 64 | PF00069 | 0.587 |
MOD_Plk_1 | 85 | 91 | PF00069 | 0.333 |
MOD_Plk_2-3 | 58 | 64 | PF00069 | 0.605 |
MOD_Plk_4 | 58 | 64 | PF00069 | 0.587 |
MOD_Plk_4 | 85 | 91 | PF00069 | 0.419 |
MOD_ProDKin_1 | 109 | 115 | PF00069 | 0.377 |
MOD_SUMO_rev_2 | 32 | 42 | PF00179 | 0.691 |
MOD_SUMO_rev_2 | 58 | 68 | PF00179 | 0.600 |
TRG_ENDOCYTIC_2 | 98 | 101 | PF00928 | 0.313 |
TRG_ER_diArg_1 | 50 | 52 | PF00400 | 0.601 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PEH8 | Leptomonas seymouri | 90% | 100% |
A0A0S4JTI1 | Bodo saltans | 68% | 100% |
A0A1X0P7G0 | Trypanosomatidae | 78% | 100% |
A0A3Q8IIA2 | Leishmania donovani | 97% | 100% |
A4HIX0 | Leishmania braziliensis | 92% | 100% |
A4I699 | Leishmania infantum | 97% | 100% |
D0A540 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 80% | 100% |
Q4Q6Q8 | Leishmania major | 96% | 100% |